Microenvironmental pH modulation in solid dosage forms

Journal of Pharmaceutical Sciences

Volumn 96, Issue 5, 2007, Pages 948-959

  Farag Badawy, Sherif I ^a   Hussain, Munir A ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Absorption; Bioavailability; Chemical stability; Dissolution; Solid state stability

Indexed keywords

ANTACID AGENT; BMS 561389; CARBOMER; CITRIC ACID; FUMARIC ACID; FUROSEMIDE; HEXAPEPTIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; MAGNESIUM CARBONATE; MICROSPHERE; NOSCAPINE; PAPAVERINE; PROTON; RAZAXABAN; ROXIFIBAN; SUCCINIC ACID; TARTARIC ACID; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE SULFATE; ZINC CARBONATE;

CRYSTALLIZATION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG GRANULATION; DRUG SOLUBILITY; DRUG STABILITY; HYDROLYSIS; MICROENVIRONMENT; PH MEASUREMENT; SHORT SURVEY;

EID: 34249098770     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20932     Document Type: Review

References (44)

1. Badawy SIF, Williams RC, Gilbert D. 1999. Effect of different acids on solid state stability of an ester prodrug of a IIb/IIIa antagonist. Pharm Dev Technol 4:325-331.
2. Glombitza BW, Oelkrug D, Schmidt PC. 1994. Surface acidity of solid pharmaceutical excipients. Part 1. Determination of the surface acidity. Eur J Pharm Biopharm 4:289-293.
3. Glombitza BW, Schmidt PC. 1995. Surface acidity of solid pharmaceutical excipients. Part 2. Effect of the surface acidity on the decomposition rate of acetylsalicylic acid. Eur J Pharm Biopharm 41:114-119.
4. Zinchuck AV, Hancock BC, Shalaev EY, Reddy RD, Govindarajan R, Novak E. 2005. The influence of measurement conditions on the Hammett acidity function of solid pharmaceutical excipients. Eur J Pharm Biopharm 61:158-170.
5. Mäder K, Bittner B, Li Y, Wohlauf W, Kissel T. 1998. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks. Pharm Res 15:787-793.
6. Brunner A, Mader K, Gopferich A. 1999. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm Res 16:847-853.
7. Mader K, Gallez B, Liu KJ, Swartz HM. 1996. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials 17:457-461.
8. Fu K, Pack DW, Klibanov AM, Langer R. 2000. Visual evidence of an acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 17:100-106.
9. Doherty C, York P. 1989. Microenvironmental pH control of drug dissolution. Int J Pharm 50:223-232.
10. Delonca H, Joachim J, Joachim G, Cantos A. 1975. Granulation de l'acide acetylsalicylique par voie humide. Influence du pH et de certains adjuvants de stabilization. IL Farmaco 30:89-97.
11. Brandl M, Magill A, Rudraraju V, Gordon MS. 1995. Approaches for improving the stability of ketorolac in powder blends. J Pharm Sci 84:1151-1153.
12. Tabata T, Makino T, Kashihara T, Hirari S, Kitamori N, Toguchi H. 1992. Stabilization of new antiulcer drug (lansoprazole) in the solid dosage forms. Drug Dev Ind Pharm 18:1437-1447.
13. Chen JG, Markovitz DA, Yang AY, Rabel SR, Pang J, Dolinsky O, Wu LS, Alasandro M. 2000. Degradation of a fluoropyridinyl drug in capsule formulation: Degradant identification, proposed degradation mechanism, and formulation optimization. Pharm Dev Technol 5:561-570.
14. Oliyai C, Patel JP, Carr L, Borchardt RT. 1994. Chemical pathways of peptide degradation. VII. Solid state chemical instability of an aspartyl residue in a model hexapeptide. Pharm Res 11: 901-908.
15. Strickley RG, Anderson BD. 1996. Solid state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions. Pharm Res 13:1142-1153.
16. Strickley RG, Viso GC, Lin LH, Gu L. 1989. An unexpected pH effect of moexipril lyophilized powder. Pharm Res 6:971-975.
17. Song Y, Schowen RL, Borchardt RT, Topp EM. 2001. Effect of pH on the rate of asparagine deamidation in polymeric formulations: pH-rate profile. J Pharm Sci 90:141-156.
18. Govindarajan R, Chatterjee K, Gatlin L, Surynarayanan R, Shalaev EY. 2006. Impact of freeze-drying on ionization of sulfonephthalein probe molecules in trehalose-citrate systems. J Pharm Sci 95:1498-1510.
19. Badawy SIF, Williams RC, Gilbert D. 1999. Chemical stability of an ester prodrug of a IIb/IIIa antagonist in solid dosage forms. J Pharm Sci 8:428-433.
20. Gu L, Strickley RG, Chi LH, Chowhan ZT. 1990. Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: Dry powder vs wet granulation. Pharm Res 7:379-383.
21. Irwin WJ, Iqbal M. 1991. Solid-state stability: The effect of grinding solvated excipients. Int J Pharm 75:211-218.
22. Waterman KC, Adami RC, Alsante KM, Antipas AS, Wang H. 2002. Hydrolysis in pharmaceutical formulations. Pharm Dev Technol 7:113-146.
23. Badawy SIF, Vickery R, Shah K, Hussain MA. 2004. Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate. Pharm Dev Technol 9:239-245.
24. Badawy SIF. 2001. Effect of salt form on chemical stability of an ester prodrug of a IIb/IIIa antagonist in solid dosage forms. Int J Pharm 223:81-87.
25. Shenderova A, Burke TG, Schwendeman SP. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res 16:241-248.
26. Shao PG, Bailey LC. 2000. Porcine insulin biodegradable polyester microspheres: Stability and in vitro release characteristics. Pharm Dev Technol 5:1-9.
27. Lu W, Park TG. 1995. Protein release from poly(lactic-co-glycolic acid) microspheres. J Pharm Sci Tech 49:13-19.
28. Cleland JL, Mac A, Boyd B, Yang J, Duenas ET, Yeung D, Brooks D, Hsu C, Chu H, Mukku V, Jones AJS. 1997. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) PLGA microspheres. Pharm Res 14:420-425.
29. Li L, Schwendeman SP. 2005. Mapping neutral microclimate pH in PLGA microspheres. J Control Release 101:163-173.
30. Shao PG, Bailey LC. 1999. Stabilization of pH induced degradation of porcine insulin in biodegradable polyester microspheres. Pharm Dev Technol 4:633-642.
31. Marinina J, Shenderova A, Mallery SR, Schwendeman SP. 2000. Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres. Pharm Res 17:677-683.
32. Serajuddin ATM, Jarowski CI. 1985. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. Part 2. Salicylic acid, theophylline and benzoic acid. J Pharm Sci 74:148-154.
33. Serajuddin ATM, Jarowski CI. 1985. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. Part 1. Phenazopyridine J Pharm Sci 74:142-147.
34. Doherty C, York P. 1987. Mechanisms of dissolution of frusemide PVP solid dispersions. Int J Pharm 34:197-205.
35. Doherty C, York P. 1989. In vitro pH dissolution dependence and in vivo bioavailability of frusemide-PVP solid dispersions. J Pharm Pharmacol 41:73-78.
36. Badawy SIF, Gray D, Zhao F, Sun D, Schuster A, Hussain MA. 2006. Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389. Pharm Res 23: 989-996.
37. Timmins P, Delargy AM, Howard JR. 1997. Optimization and characterization of a pH-independent extended release hydrophilic matrix tablet. Pharm Dev Technol 2:25-31.
38. Streubel A, Siepmann J, Dashevsky A, Bodmeier R. 2000. pH-independent release of weakly basic drug from water-insoluble and -soluble matrix tablets. J Control Release 67:101-110.
39. Gabr KE. 1992. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur J Pharm Biopahrm 38:199-202.
40. Thoma K, Zimmer T. 1990. Retardation of weakly basic drugs with diffusion tablets. Int J Pharm 58: 197-202.
41. Tatavarti AS, Hoag SW. 2006. Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J Pharm Sci 95:1459-1468.
42. Akiyama Y, Yoshioka M, Horibe H, Hirai S, Kitamori N, Toguchi H. 1994. pH-independent controlled release microspheres using polyglycerol esters of fatty acids. J Pharm Sci 83:1600-1607.
43. Tatavarti AS, Mehta KA, Augsburger LL, Hoag SW. 2004. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J Pharm Sci 93:2319-2331.
44. Rao VM, Engha K, Qiu Y. 2003. Design of pH-independent controlled release matrix tablets for acidic drugs. Int J Pharm 252:81-86.